Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Get an introduction to all features of this page

Urogen Pharma Ltd. Stock

Price
Target price
€16.70

€16.70

-1.180%
-0.2
-1.180%
-
 
22:26 / Tradegate WKN: A2DTCV / Name: Urogen Pharma Ltd. / Stock / ? /
Please give a prediction to see the opinions of the community
Buy
None
Sell
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Urogen Pharma Ltd. in the next few years
Wizard

Urogen Pharma Ltd. Stock

We can see a decrease in the price for Urogen Pharma Ltd.. Compared to yesterday it has lost -€0.200 (-1.180%).
For the coming years our community has positive and negative things to say abot the Urogen Pharma Ltd. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Balance Sheet Risk" there were negative voices in the community.
What does Urogen Pharma Ltd. do?

Pros and Cons of Urogen Pharma Ltd. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Your Opinion
Legal notice

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2024-08-01

When analyzing the financials of Urogen Pharma Ltd., the picture that emerges is mixed, characterized by significant challenges against a backdrop of potential growth and innovation. The company, focused on developing therapies for urological cancers, is experiencing substantial losses. However, it’s essential to look deeper into the financial statements and ratios to understand where Urogen Pharma stands in the competitive landscape.

*Pros: *

Market Capitalization: With a sizable market capitalization of approximately $563 million, Urogen Pharma has considerable recognition in the market. Together with a Wall Street target price of $42.6, there is an implied optimism about the company’s future growth potential, indicating that investors may see it as undervalued relative to its future prospects.

Show more
Register To Post